| Combined estrogen-progestin methods | - Reduction in menstrual cramps
- Reduction in pelvic pain related to endometriosis
- Reduction of menorrhagia, with improvement in iron deficiency anemia related to blood loss
- Reduction in risk of ectopic pregnancy
- Reduction in symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder
- Reduction in risk of benign breast disease
- Reduction in development of new ovarian cysts (true for higher dose estrogen pills only, which suppress ovulation), but no effect on existing ovarian cysts
- Reduction in ovarian cancer, including some hereditary forms, such as those associated with mutations in the BRCA1 or BRCA2 gene, presumably due to inhibition of ovarian stimulation
- Reduction in endometrial cancer due to the progestin effect
- Reduction in colorectal cancer in current users
- Reduction in moderate acne
- Reduction in hirsutism
- More regular menstrual cycles
|
| Hormonal IUD (levonorgestrel) | - Reduction in menstrual cramps
- Reduction in pelvic pain related to endometriosis
- Reduction of menorrhagia, with improvement in iron deficiency anemia related to blood loss
- Reduction in endometrial hyperplasia
- Reduction in cervical cancer
- Reduction in pelvic inflammatory disease
|
| Copper IUD | - Continued menstrual cyclicity
- Reduced risk of cervical cancer
|
| Progestin-only injection | - Reduction in menstrual cramps
- Reduction in menstrual bleeding
- Reduction in risk of endometrial cancer
|
| Progestin-only pills | - Reduction in risk of endometrial cancer
|
